Gilead Sciences is a biopharmaceutical company that develops, manufactures, and commercializes therapies for the treatment of life-threatening infectious diseases, including HIV/AIDS, liver diseases, and cancer. The company's key products include Sovaldi, Harvoni, Epclusa, and Biktarvy, which are used to treat various viral infections and cancers. As a leader in the development of antiviral therapies, Gilead Sciences plays a significant role in improving patient outcomes and addressing some of the world's most pressing public health challenges.
S&P 500 closing prices, top movers, and sector performance — delivered daily.